These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27513191)

  • 1. A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome.
    Wassif CA; Kratz L; Sparks SE; Wheeler C; Bianconi S; Gropman A; Calis KA; Kelley RI; Tierney E; Porter FD
    Genet Med; 2017 Mar; 19(3):297-305. PubMed ID: 27513191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a hypomorphic Smith-Lemli-Opitz syndrome mouse model and efficacy of simvastatin therapy.
    Correa-Cerro LS; Wassif CA; Kratz L; Miller GF; Munasinghe JP; Grinberg A; Fliesler SJ; Porter FD
    Hum Mol Genet; 2006 Mar; 15(6):839-51. PubMed ID: 16446309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndrome.
    Tierney E; Conley SK; Goodwin H; Porter FD
    Am J Med Genet A; 2010 Jan; 152A(1):91-5. PubMed ID: 20014133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome.
    Jira PE; Wevers RA; de Jong J; Rubio-Gozalbo E; Janssen-Zijlstra FS; van Heyst AF; Sengers RC; Smeitink JA
    J Lipid Res; 2000 Aug; 41(8):1339-46. PubMed ID: 10946022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts.
    Wassif CA; Krakowiak PA; Wright BS; Gewandter JS; Sterner AL; Javitt N; Yergey AL; Porter FD
    Mol Genet Metab; 2005 Jun; 85(2):96-107. PubMed ID: 15896653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
    Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
    J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz Syndrome.
    Hall P; Michels V; Gavrilov D; Matern D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S
    Mol Genet Metab; 2013; 110(1-2):176-8. PubMed ID: 23628460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS).
    Haas D; Garbade SF; Vohwinkel C; Muschol N; Trefz FK; Penzien JM; Zschocke J; Hoffmann GF; Burgard P
    J Inherit Metab Dis; 2007 Jun; 30(3):375-87. PubMed ID: 17497248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome.
    Roullet JB; Merkens LS; Pappu AS; Jacobs MD; Winter R; Connor WE; Steiner RD
    J Inherit Metab Dis; 2012 Sep; 35(5):859-69. PubMed ID: 22391996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.
    Wassif CA; Maslen C; Kachilele-Linjewile S; Lin D; Linck LM; Connor WE; Steiner RD; Porter FD
    Am J Hum Genet; 1998 Jul; 63(1):55-62. PubMed ID: 9634533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient with Smith-Lemli-Opitz syndrome: novel mutation of the DHCR7 gene and effects of therapy with simvastatin and cholesterol supplement.
    Szabó GP; Oláh AV; Kozak L; Balogh E; Nagy A; Blahakova I; Oláh E
    Eur J Pediatr; 2010 Jan; 169(1):121-3. PubMed ID: 19365639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p.Phe174Ser mutation is associated with mild forms of Smith Lemli Opitz Syndrome.
    Tucci A; Ronzoni L; Arduino C; Salmin P; Esposito S; Milani D
    BMC Med Genet; 2016 Mar; 17():22. PubMed ID: 26969503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D levels in Smith-Lemli-Opitz syndrome.
    Movassaghi M; Bianconi S; Feinn R; Wassif CA; Porter FD
    Am J Med Genet A; 2017 Oct; 173(10):2577-2583. PubMed ID: 28796426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome.
    Chan YM; Merkens LS; Connor WE; Roullet JB; Penfield JA; Jordan JM; Steiner RD; Jones PJ
    Pediatr Res; 2009 Jun; 65(6):681-5. PubMed ID: 19430384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndrome.
    Koo G; Conley SK; Wassif CA; Porter FD
    Am J Med Genet A; 2010 Aug; 152A(8):2094-8. PubMed ID: 20635399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Historical aspects of the Smith-Lemli-Opitz syndrome].
    Bzdúch V; Behúlová D; Skodová J; Skokňová M; Kozák L
    Cas Lek Cesk; 2014; 153(1):36-9. PubMed ID: 24506692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome.
    Witsch-Baumgartner M; Fitzky BU; Ogorelkova M; Kraft HG; Moebius FF; Glossmann H; Seedorf U; Gillessen-Kaesbach G; Hoffmann GF; Clayton P; Kelley RI; Utermann G
    Am J Hum Genet; 2000 Feb; 66(2):402-12. PubMed ID: 10677299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild Smith-Lemli-Opitz syndrome: further delineation of 5 Polish cases and review of the literature.
    Jezela-Stanek A; Ciara E; Malunowicz EM; Korniszewski L; Piekutowska-Abramczuk D; Popowska E; Krajewska-Walasek M
    Eur J Med Genet; 2008; 51(2):124-40. PubMed ID: 18249054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients.
    Koczok K; Horváth L; Korade Z; Mezei ZA; Szabó GP; Porter NA; Kovács E; Mirnics K; Balogh I
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.
    Fitzky BU; Moebius FF; Asaoka H; Waage-Baudet H; Xu L; Xu G; Maeda N; Kluckman K; Hiller S; Yu H; Batta AK; Shefer S; Chen T; Salen G; Sulik K; Simoni RD; Ness GC; Glossmann H; Patel SB; Tint GS
    J Clin Invest; 2001 Sep; 108(6):905-15. PubMed ID: 11560960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.